AIIMS Nagpur

Nagpur: The National Centre for Disease Control (NCDC), New Delhi, has sanctioned Rs 30 crore to the All India Institute of Medical Sciences (AIIMS Nagpur) for establishing a Biosafety Level-III (BSL-III) laboratory to strengthen the region’s capacity to detect, investigate and study emerging and high-risk infectious diseases.

The laboratory is expected to become operational in about a year. AIIMS executive director Prashant Joshi said that space had already been earmarked for the facility and that the sanctioned amount would be used to develop its infrastructure. He added that manpower and equipment would be funded through separate budgets, reports the Daily.

Also Read:No cause for panic, Govt closely monitoring seasonal influenza: ICMR DG

The proposed laboratory is expected to reduce the institute’s dependence on the National Institute of Virology (NIV), Pune, for advanced testing and strengthen Maharashtra’s capacity for infectious disease surveillance and research, Joshi said. 

The development comes at a time when increasing human-animal interaction, deforestation and climate change are creating conditions for the emergence and spread of zoonotic infections. “The human-animal interface is increasing because of deforestation. We are invading the habitat of animals. Climate change and deforestation are very important factors,” said Joshi, as reported by the Economic Times.

Meena Mishra, head of the department of microbiology at AIIMS-Nagpur, said early detection of emerging infections requires both syndromic and genomic surveillance.

While syndromic surveillance helps identify unusual patterns of illness based on symptoms, genomic surveillance enables researchers to identify mutations and emerging pathogens through whole-genome sequencing.

“If the incidence of a disease is increasing, it should be picked up through proper syndromic surveillance as well as genomics at an early stage so that proper preventive measures can be implemented,” Mishra said, reports Economic Times.

Meena Mishra, head of the department of microbiology at AIIMS-Nagpur, said early detection of emerging infections requires both syndromic and genomic surveillance.

While syndromic surveillance helps identify unusual patterns of illness based on symptoms, genomic surveillance enables researchers to identify mutations and emerging pathogens through whole-genome sequencing.

The IRDL is expected to become functional within three months, significantly expanding the institute’s capacity to diagnose infections and support infectious disease research.

Mishra said the microbiology department at AIIMS Nagpur was already participating in national surveillance programmes and had contributed to more than 250 laboratories being granted PCR-testing status.

Also Read:AIIMS Nagpur resident doctors call off protest after security assurance

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .